newsfilter
← Latest News
GlobeNewswire·

Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences

FOSTER CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic